Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:06 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2016-12. Completion: 2018-05 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (PF708) (drug)
Teriparatide (Forteo) (drug)
Where the study takes place — 26 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Radiant Research Birmingham, Alabama, United States Site recruitment: Not reported
The Orthopaedic GroupMobile, Alabama, United States
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2015-04. Completion: 2017-12-07 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
anti-osteoporotic medication (drug) — also listed as: all available anti-osteoporotic medication
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, MEDICAL SCHOOL, 2nd DEPARTMENT OF ORTHOPAEDIC SURGERY Athens, Attica, Greece Site recruitment: Not reported
Democritus University of Thrace, School of Medicine, Department of Orthopaedic Surgery Alexandroupoli, Evros, Greece Site recruitment: Not reported
Orthopaedic Department, Faculty of Medicine, School of Health Sciences, University of Thessalia Larissa, Greece Site recruitment: Not reported
Aristotle University of Thessaloniki, 3rd University Orthopaedic Department, Papageorgiou General Hospital Thessaloniki, Greece Site recruitment: Not reported
Start: 2011-02. Completion: 2015-11 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (drug) — also listed as: Forteo
Placebo (drug) — also listed as: carrier
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Michigan Center for Oral Health Research Ann Arbor, Michigan, United States Site recruitment: Not reported
Start: 2013-10. Completion: 2017-10 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (drug)
Oral PTH (1-34) (drug) — also listed as: Teriparatide
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2012-12. Completion: 2016-09 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
teriparatide (drug) — also listed as: Forteo
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Pittsburgh, Osteoporosis Prevention & Treatment Center Pittsburgh, Pennsylvania, United States Site recruitment: Not reported
Argentina · Australia · Belgium · Denmark · Germany · Hong Kong · Mexico · Norway · Poland · Russia · South Africa · South Korea · Spain · United States
Registry dates and results
Start: 2007-05-14. Completion: 2008-12-26 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Ronacaleret (drug) — also listed as: SB-751689
Teriparatide (drug)
Alendronate (drug)
Where the study takes place — 49 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
GSK Investigational Site Oakland, California, United States Site recruitment: Not reported
GSK Investigational Site Palm Desert, California, United States Site recruitment: Not reported
GSK Investigational Site Walnut Creek, California, United States Site recruitment: Not reported
GSK Investigational Site Decatur, Georgia, United States Site recruitment: Not reported
GSK Investigational Site Bethesda, Maryland, United States Site recruitment: Not reported
GSK Investigational Site Akron, Ohio, United States Site recruitment: Not reported
GSK Investigational Site Cleveland, Ohio, United States Site recruitment: Not reported
GSK Investigational Site Portland, Oregon, United States Site recruitment: Not reported
GSK Investigational Site Duncansville, Pennsylvania, United States Site recruitment: Not reported
GSK Investigational Site Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina Site recruitment: Not reported
GSK Investigational Site Buenos Aires, Argentina Site recruitment: Not reported
GSK Investigational Site Buenos Aires, Argentina Site recruitment: Not reported
GSK Investigational Site St Leonards, New South Wales, Australia Site recruitment: Not reported
GSK Investigational Site Footscray, Victoria, Australia Site recruitment: Not reported
GSK Investigational Site Geelong, Victoria, Australia Site recruitment: Not reported
GSK Investigational Site Heidelberg, Victoria, Australia Site recruitment: Not reported
GSK Investigational Site Ghent, Belgium Site recruitment: Not reported
GSK Investigational Site Liège, Belgium Site recruitment: Not reported
GSK Investigational Site Tienen, Belgium Site recruitment: Not reported
GSK Investigational Site Ballerup Municipality, Denmark Site recruitment: Not reported
GSK Investigational Site Frankfurt am Main, Hesse, Germany Site recruitment: Not reported
GSK Investigational Site Berlin, Germany Site recruitment: Not reported
GSK Investigational Site Berlin, Germany Site recruitment: Not reported
GSK Investigational Site Berlin, Germany Site recruitment: Not reported
GSK Investigational Site Berlin, Germany Site recruitment: Not reported
GSK Investigational Site Hamburg, Germany Site recruitment: Not reported
GSK Investigational Site Hamburg, Germany Site recruitment: Not reported
GSK Investigational Site Hong Kong, Hong Kong Site recruitment: Not reported
GSK Investigational Site Shatin, Hong Kong Site recruitment: Not reported
GSK Investigational Site Mexico City, Mexico Site recruitment: Not reported
GSK Investigational Site Bergen, Norway Site recruitment: Not reported
GSK Investigational Site Hamar, Norway Site recruitment: Not reported
GSK Investigational Site Oslo, Norway Site recruitment: Not reported
GSK Investigational Site Grudziądz, Poland Site recruitment: Not reported
GSK Investigational Site Warsaw, Poland Site recruitment: Not reported
GSK Investigational Site Wroclaw, Poland Site recruitment: Not reported
GSK Investigational Site Moscow, Russia Site recruitment: Not reported
GSK Investigational Site Moscow, Russia Site recruitment: Not reported
GSK Investigational Site Panorama, South Africa Site recruitment: Not reported
GSK Investigational Site Rosebank, South Africa Site recruitment: Not reported
GSK Investigational Site Somerset West, South Africa Site recruitment: Not reported
GSK Investigational Site Seoul, South Korea Site recruitment: Not reported
GSK Investigational Site Suwon, South Korea Site recruitment: Not reported
GSK Investigational Site Barcelona, Spain Site recruitment: Not reported
GSK Investigational Site Barcelona, Spain Site recruitment: Not reported
GSK Investigational Site Madrid, Spain Site recruitment: Not reported
GSK Investigational Site Madrid, Spain Site recruitment: Not reported
GSK Investigational Site Santiago de Compostela, Spain Site recruitment: Not reported
GSK Investigational Site Santiago de Compostela, Spain Site recruitment: Not reported
Start: 2007-04. Completion: 2009-06 (may be estimated). Results are posted in this registry.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
teriparatide (drug) — also listed as: PTH
Placebo (drug)
BA058 20 µg (drug)
BA058 40 µg (drug)
BA058 80 µg (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Radius Health, Inc. Cambridge, Massachusetts, United States Site recruitment: Not reported
Start: 2013-08. Completion: 2018-08 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Standard Clinical Practice Regimen (drug) — also listed as: 18 months Forteo followed by 18 months Prolia
Experimental Cyclic Regimen (drug) — also listed as: three separate 6 month cycles of daily Forteo, each followed by one of Prolia
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Helen Hayes Hospital West Haverstraw, New York, United States Site recruitment: Not reported
Start: 2005-09. Completion: 2017-11 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (drug)
Alendronate (drug)
Calcium (dietary_supplement)
Vitamin D3 (dietary_supplement)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Helen Hayes Hospital West Haverstraw, New York, United States Site recruitment: Not reported
Start: 2008-07. Completion: 2012-12 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Virtual Bone Biopsy (other) — also listed as: VBB
Teriparatide (drug) — also listed as: Forteo
Zoledronic Acid (drug) — also listed as: Reclast
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Pennsylvania Philadelphia, Pennsylvania, United States Site recruitment: Not reported
Start: 2008-09. Completion: 2016-02-22 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Placebo (drug)
Teriparatide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Massachusetts General Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Start: 2006-08. Completion: 2008-04 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
zoledronic acid (drug) — also listed as: zometa
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The Cleveland Clinic Foundation Cleveland, Ohio, United States Site recruitment: Not reported
Start: 2011-08. Completion: 2016-07-28 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (drug) — also listed as: Forteo
calcium citrate (drug)
Vitamin D (drug)
TNF antagonist (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Massachusetts General Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Brigham and Women's Hospital Boston, Massachusetts, United States Site recruitment: Not reported
University of Massachusetts Medical School Worcester, Massachusetts, United States Site recruitment: Not reported
Start: 2013-01. Completion: 2014-08 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide 40-mcg subcutaneous injection (drug) — also listed as: Forteo®
Denosumab Injection (drug)
Alendronate Oral Tablet (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Massachusetts General Hospital Boston, Massachusetts, United States Site recruitment: Not reported
Argentina · Brazil · Czechia · Denmark · Estonia · Hong Kong · Lithuania · Poland · Romania · United States
Registry dates and results
Start: 2011-04. Completion: 2014-10 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Placebo (drug)
BA058 80 mcg (drug) — also listed as: abaloparatide, Abaloparatide-SC
teriparatide (drug) — also listed as: Forteo, Forsteo
Where the study takes place — 28 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Facility not reported Lakewood, Colorado, United States Site recruitment: Not reported
Facility not reported Miami, Florida, United States Site recruitment: Not reported
Facility not reported North Miami, Florida, United States Site recruitment: Not reported
Facility not reported Atlanta, Georgia, United States Site recruitment: Not reported
Facility not reported Bethesda, Maryland, United States Site recruitment: Not reported
Facility not reported Buenos Aires, Argentina Site recruitment: Not reported
Facility not reported Brasília, Brazil Site recruitment: Not reported
Facility not reported Curitiba, Brazil Site recruitment: Not reported
Facility not reported Rio de Janeiro, Brazil Site recruitment: Not reported
Facility not reported São Paulo, Brazil Site recruitment: Not reported
Facility not reported Vitória, Brazil Site recruitment: Not reported
Facility not reported Brno, Czechia Site recruitment: Not reported
Facility not reported Pardubice, Czechia Site recruitment: Not reported
Facility not reported Prague, Czechia Site recruitment: Not reported
Facility not reported Aalborg, Denmark Site recruitment: Not reported
Facility not reported Ballerup Municipality, Denmark Site recruitment: Not reported
Facility not reported Vejle, Denmark Site recruitment: Not reported
Facility not reported Tallinn, Estonia Site recruitment: Not reported
Facility not reported Tartu, Estonia Site recruitment: Not reported
Facility not reported Hong Kong, Hong Kong Site recruitment: Not reported
Facility not reported Vilnius, Lithuania Site recruitment: Not reported
Facility not reported Bialystok, Poland Site recruitment: Not reported
Facility not reported Katowice, Poland Site recruitment: Not reported
Facility not reported Kielce, Poland Site recruitment: Not reported
Facility not reported Lodz, Poland Site recruitment: Not reported
Facility not reported Warsaw, Poland Site recruitment: Not reported
Facility not reported Zgierz, Poland Site recruitment: Not reported
Facility not reported Bucharest, Romania Site recruitment: Not reported
Start: 2013-08. Completion: 2014-02 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
AK159 (drug)
MN-10-T (drug)
Placebo (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Facility not reported Fukuoka, Japan Site recruitment: Not reported
Facility not reported Kumamoto, Japan Site recruitment: Not reported
Facility not reported Sumida City, Japan Site recruitment: Not reported
Start: 2006-01. Completion: 2019-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Bis, SERM Teriparatide, Denosumab (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tomidahama Hospital Yokkaichi, Mie-ken, Japan Site recruitment: Recruiting
Start: 2010-08. Completion: 2015-08 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Teriparatide (drug) — also listed as: forteo
placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Helen Hayes Hospital West Haverstraw, New York, United States Site recruitment: Not reported
Start: 2016-10. Completion: 2017-10 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Forsteo (drug) — also listed as: Teriparatide hormone
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Nottingham University Hospitals NHS Trust Nottingham, United Kingdom Site recruitment: Recruiting
Start: 2010-09. Completion: 2017-10 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tomidahama Hospital Yokkaichi, Mie-ken, Japan Site recruitment: Recruiting
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.